BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37603131)

  • 1. Magnetic resonance-based imaging biopsy with signatures including topological Betti number features for prediction of primary brain metastatic sites.
    Egashira M; Arimura H; Kobayashi K; Moriyama K; Kodama T; Tokuda T; Ninomiya K; Okamoto H; Igaki H
    Phys Eng Sci Med; 2023 Dec; 46(4):1411-1426. PubMed ID: 37603131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
    Meißner AK; Gutsche R; Galldiks N; Kocher M; Jünger ST; Eich ML; Nogova L; Araceli T; Schmidt NO; Ruge MI; Goldbrunner R; Proescholdt M; Grau S; Lohmann P
    J Neurooncol; 2023 Jul; 163(3):597-605. PubMed ID: 37382806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic combination of a topologically invariant imaging signature and a biomarker for the accurate prediction of symptomatic radiation pneumonitis before stereotactic ablative radiotherapy for lung cancer: A retrospective analysis.
    Ninomiya K; Arimura H; Yoshitake T; Hirose TA; Shioyama Y
    PLoS One; 2022; 17(1):e0263292. PubMed ID: 35100322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study.
    Ortiz-Ramón R; Larroza A; Ruiz-España S; Arana E; Moratal D
    Eur Radiol; 2018 Nov; 28(11):4514-4523. PubMed ID: 29761357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images.
    Zhang J; Jin J; Ai Y; Zhu K; Xiao C; Xie C; Jin X
    Eur Radiol; 2021 Feb; 31(2):1022-1028. PubMed ID: 32822055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer.
    Ahn SJ; Kwon H; Yang JJ; Park M; Cha YJ; Suh SH; Lee JM
    Sci Rep; 2020 Jun; 10(1):8905. PubMed ID: 32483122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer.
    Park YW; An C; Lee J; Han K; Choi D; Ahn SS; Kim H; Ahn SJ; Chang JH; Kim SH; Lee SK
    Neuroradiology; 2021 Mar; 63(3):343-352. PubMed ID: 32827069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
    Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
    Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust radiogenomics approach to the identification of EGFR mutations among patients with NSCLC from three different countries using topologically invariant Betti numbers.
    Ninomiya K; Arimura H; Chan WY; Tanaka K; Mizuno S; Muhammad Gowdh NF; Yaakup NA; Liam CK; Chai CS; Ng KH
    PLoS One; 2021; 16(1):e0244354. PubMed ID: 33428651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.
    Fan Y; Wang X; Yang C; Chen H; Wang H; Wang X; Hou S; Wang L; Luo Y; Sha X; Yang H; Yu T; Jiang X
    J Magn Reson Imaging; 2023 Dec; 58(6):1838-1847. PubMed ID: 37144750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Learning Based on Enhanced MRI T1 Imaging to Differentiate Small-cell and Non-small-cell Primary Lung Cancers in Patients with Brain Metastases.
    Sui L; Chang S; Xue L; Wang J; Zhang Y; Yang K; Gao BL; Yin X
    Curr Med Imaging; 2023; 19(13):1541-1548. PubMed ID: 36717988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative MRI-Based Radiomics of Brain Metastasis to Assess T790M Resistance Mutation After EGFR-TKI Treatment in NSCLC.
    Fan Y; He L; Yang H; Wang Y; Su J; Hou S; Luo Y; Jiang X
    J Magn Reson Imaging; 2023 Jun; 57(6):1778-1787. PubMed ID: 36165534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
    Chen BT; Jin T; Ye N; Mambetsariev I; Daniel E; Wang T; Wong CW; Rockne RC; Colen R; Holodny AI; Sampath S; Salgia R
    Magn Reson Imaging; 2020 Jun; 69():49-56. PubMed ID: 32179095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics of Brain MRI: Utility in Prediction of Metastatic Tumor Type.
    Kniep HC; Madesta F; Schneider T; Hanning U; Schönfeld MH; Schön G; Fiehler J; Gauer T; Werner R; Gellissen S
    Radiology; 2019 Feb; 290(2):479-487. PubMed ID: 30526358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery.
    Jiang Z; Wang B; Han X; Zhao P; Gao M; Zhang Y; Wei P; Lan C; Liu Y; Li D
    Eur Radiol; 2022 Apr; 32(4):2266-2276. PubMed ID: 34978579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.
    Huang CY; Lee CC; Yang HC; Lin CJ; Wu HM; Chung WY; Shiau CY; Guo WY; Pan DH; Peng SJ
    J Neurooncol; 2020 Feb; 146(3):439-449. PubMed ID: 32020474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
    Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
    Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
    Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.